Stocks›Healthcare›TKNO

TKNO

Alpha Teknova, Inc.

NasdaqResearch view

Alpha Teknova, Inc. operates in the In Vitro & In Vivo Diagnostic Substances industry.

$8.75−2.78%

Oct 6 close · 1D EOD · Databento

HealthcareIn Vitro & In Vivo Diagnostic SubstancesSmall-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 7, 2024, after the close.

Last report

Aug 5, 2026+16.40%

after the close

Last 4, next close

median 11.53% either way

up 3 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Aug 5Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗+16.40%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

23 big days in a year, and what we hold on each

A big day is a close more than 7.68% from the one before, three times TKNO’s median day (2.56%). On 1 of the 23, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±7.68%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayTKNOWhat we hold that dayGroup (median of 4) · each

1 Oct 3, 2025−8.29%
Before our storiesgroup +2.2%, did not move with it
1Oct 3, 2025−8.29%
Before our stories
+2.2% did not move with itIDXX −0.4 · LNTH +2.2 · CLDX +2.2 · NEOG +4.6
2 Oct 20, 2025+12.09%
Before our storiesgroup +1.5%, did not move with it
2Oct 20, 2025+12.09%
Before our stories
+1.5% did not move with itCLDX +3.1 · LNTH +1.8 · IDXX +1.3 · NEOG +0.2
3 Nov 12, 2025−8.98%
Before our storiesgroup −0.2%, did not move with it
3Nov 12, 2025−8.98%
Before our stories
−0.2% did not move with itNEOG −0.9 · CLDX −0.5 · IDXX +0.1 · LNTH +2.1
4 Dec 3, 2025+8.82%
Before our storiesgroup +1.2%, did not move with it
4Dec 3, 2025+8.82%
Before our stories
+1.2% did not move with itCLDX +4.3 · LNTH +2.1 · NEOG +0.3 · IDXX −0.9
5 Dec 23, 2025−8.07%
Before our storiesgroup −2.4%, did not move with it
5Dec 23, 2025−8.07%
Before our stories
−2.4% did not move with itIDXX −2.8 · CLDX −2.5 · LNTH −2.2 · NEOG +0.3
6 Jan 16, 2026−10.27%
Before our storiesgroup −1.0%, did not move with it
6Jan 16, 2026−10.27%
Before our stories
−1.0% did not move with itNEOG −2.2 · LNTH −1.8 · CLDX −0.2 · IDXX +0.5
7 Jan 30, 2026−14.79%
Before our storiesgroup −0.1%, did not move with it
7Jan 30, 2026−14.79%
Before our stories
−0.1% did not move with itIDXX −0.9 · CLDX −0.4 · NEOG +0.1 · LNTH +0.4
8 Feb 24, 2026+9.71%
Before our storiesgroup +1.7%, did not move with it
8Feb 24, 2026+9.71%
Before our stories
+1.7% did not move with itIDXX +4.2 · CLDX +2.1 · NEOG +1.2 · LNTH +0.3
9 Feb 27, 2026+13.16%
Resultsgroup −0.7%, did not move with it
9Feb 27, 2026+13.16%
ResultsFirst close after the Feb 26 results filing
−0.7% did not move with itIDXX −0.6 · LNTH −0.7 · NEOG −0.8 · CLDX −1.8
10 Mar 2, 2026−7.75%
Before our storiesgroup −0.5%, did not move with it
10Mar 2, 2026−7.75%
Before our stories
−0.5% did not move with itIDXX −3.0 · NEOG −0.7 · CLDX −0.3 · LNTH +1.9
11 Mar 10, 2026+21.70%
Before our storiesgroup +0.4%, did not move with it
11Mar 10, 2026+21.70%
Before our stories
+0.4% did not move with itLNTH +4.0 · CLDX +1.4 · NEOG −0.5 · IDXX −1.9
12 Mar 16, 2026+7.89%
Before our storiesgroup +1.2%, did not move with it
12Mar 16, 2026+7.89%
Before our stories
+1.2% did not move with itCLDX +2.3 · IDXX +2.2 · NEOG +0.2 · LNTH −1.3
13 Mar 31, 2026+7.84%
Before our storiesgroup +4.0%, moved with TKNO
13Mar 31, 2026+7.84%
Before our stories
+4.0% moved with TKNOCLDX +7.6 · NEOG +4.3 · LNTH +3.8 · IDXX +0.9
14 Apr 2, 2026+7.85%
Before our storiesgroup +0.4%, did not move with it
14Apr 2, 2026+7.85%
Before our stories
+0.4% did not move with itIDXX +0.9 · LNTH +0.5 · NEOG +0.2 · CLDX −0.6
15 Apr 15, 2026−9.57%
Before our storiesgroup +0.4%, did not move with it
15Apr 15, 2026−9.57%
Before our stories
+0.4% did not move with itNEOG −2.0 · IDXX −0.6 · LNTH +1.4 · CLDX +1.6
16 Apr 17, 2026+9.33%
Before our storiesgroup +2.5%, did not move with it
16Apr 17, 2026+9.33%
Before our stories
+2.5% did not move with itIDXX +3.4 · NEOG +2.9 · CLDX +2.0 · LNTH −0.1
17 Apr 30, 2026+9.91%
Before our storiesgroup +3.3%, did not move with it
17Apr 30, 2026+9.91%
Before our stories
+3.3% did not move with itNEOG +4.3 · LNTH +4.3 · CLDX +2.3 · IDXX +1.3
18 May 7, 2026+9.89%
Resultsgroup −0.2%, did not move with it
18May 7, 2026+9.89%
ResultsFirst close after the May 6 results filing
−0.2% did not move with itLNTH +5.6 · NEOG +0.8 · IDXX −1.2 · CLDX −3.1
19 May 28, 2026+16.50%
Before our storiesgroup +0.8%, did not move with it
19May 28, 2026+16.50%
Before our stories
+0.8% did not move with itIDXX +3.1 · NEOG +1.1 · LNTH +0.5 · CLDX +0.2
20 May 29, 2026+15.88%
Before our storiesgroup −0.8%, did not move with it
20May 29, 2026+15.88%
Before our stories
−0.8% did not move with itLNTH −0.3 · IDXX −0.8 · CLDX −0.8 · NEOG −3.5
21 Jun 5, 2026−16.02%
Before our storiesgroup −2.1%, did not move with it
21Jun 5, 2026−16.02%
Before our stories
−2.1% did not move with itCLDX −4.4 · NEOG −2.4 · LNTH −1.8 · IDXX −0.5
22 Jun 16, 2026+11.62%
Nothing on TKNOgroup +0.4%, did not move with it
22Jun 16, 2026+11.62%
Nothing on TKNONo TKNO story, brief or results filing in our record that day
+0.4% did not move with itCLDX +0.6 · IDXX +0.5 · LNTH +0.3 · NEOG +0.1
23 Aug 6, 2026+16.40%
Resultsgroup +0.2%, did not move with it
23Aug 6, 2026+16.40%
ResultsFirst close after the Aug 5 results filing
+0.2% did not move with itCLDX +1.2 · IDXX +0.9 · LNTH −0.4 · NEOG −0.9

A story on the same day is not a cause, and a group move is not proof either. Group: the median of IDXX, LNTH, NEOG and CLDX that day, the largest companies in TKNO’s SEC industry; “moved with TKNO” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). TKNO reports after the close, so day 1 is the next close. 3 of 4 times, day 6 ended on the same side as day 1.

Reported Nov 6, 2025

day 1−2.08%day 6−7.48%

Reported Feb 26, 2026

day 1+13.16%day 6−7.46%

Reported May 6, 2026

day 1+9.89%day 6+2.20%

Reported Aug 5, 2026

day 1+16.40%day 6+31.55%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 5 report: +60.43%. Four reports is a small sample.

Every report since 2023 →

Each line is TKNO’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$483M

Revenue$40.5M+7.40%

Net income$-17.3M

EPS, diluted$-0.32+43.90%

Gross margin33.2%

Operating margin-41.9%

Return on equity-25.1%

Debt / equity0.19

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$482.7M

Enterprise Value$489.9M

Income$-17.3M

Sales$40.5M

Book/sh$1.28

Cash/sh$0.11

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio3.64

Current Ratio4.58

Debt/Eq0.19

EPS (ttm)$-0.32

EPS this Y43.9%

EPS past 3/5Y—

Sales past 3/5Y-0.7%

EPS Y/Y TTM43.9%

Sales Y/Y TTM7.4%

Shs Outstand53.69M

ROA-16.7%

ROE-25.1%

ROIC-22.4%

Gross Margin33.2%

Oper. Margin-41.9%

Profit Margin-42.6%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$36.9M

FY21

$41.4M

FY22

$36.7M

FY23

$37.7M

FY24

$40.5M

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$36.9M	$41.4M	$36.7M	$37.7M	$40.5M
Gross Profit	$17.6M	$17.5M	$10.3M	$7.2M	$13.4M
Operating Income	$-12.0M	$-49.7M	$-35.6M	$-26.1M	$-17.0M
Net Income	$-9.8M	$-47.5M	$-36.8M	$-26.7M	$-17.3M
Diluted EPS	$-0.61	$-1.69	$-1.16	$-0.57	$-0.32
Operating Cash Flow	$-9.1M	$-27.4M	$-18.8M	$-12.4M	$-8.6M
Free Cash Flow	$-28.9M	$-55.5M	$-26.7M	$-13.5M	$-9.8M

Same industry

TKNO against four same-industry peers, a year at 100

TKNO is up 81.4% in a year. Neogen is up 2.2 times and Lantheus Holdings is up 87.1%. Of these four, Celldex Therapeutics (+21.7%) and Idexx Laboratories (−14.5%) did less. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 2.2-fold rise and a 14.5% fall both read honestly.

Share this chart

TKNO +81.4%. Neogen ×2.2, Lantheus Holdings +87.1%, Celldex Therapeutics +21.7%, Idexx Laboratories −14.5%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in TKNO’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

IDXX$40.8B LNTH$6.5B NEOG$2.6B CLDX$2.5B NTLA$1.7B QDEL$739M MYGN$434M NNNN$242M

Build basket with TKNO Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.